Timing of corticosteroids in refractory septic shock: A key or wishful thinking?

Critical Care Medicine

Volumn 42, Issue 7, 2014, Pages 1733-1735

  Greenberg, Steven B ^a,b   Coursin, Douglas B ^c  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

critical illness corticosteroid insufficiency; hydrocortisone; sepsis therapy; septic shock; timing

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; HYPERTENSIVE FACTOR; METHYLPREDNISOLONE; NORADRENALIN; TUMOR NECROSIS FACTOR ALPHA;

CENTRAL VENOUS PRESSURE; CLINICAL PRACTICE; CORTICOSTEROID THERAPY; DISEASE ASSOCIATION; EDITORIAL; FIBROMYALGIA; FLUID RESUSCITATION; HUMAN; INSOMNIA; PRIORITY JOURNAL; SEPTIC SHOCK; SLEEP DISORDERED BREATHING; TREATMENT DURATION;

FEMALE; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; INTENSIVE CARE UNITS; MALE; SHOCK, SEPTIC;

EID: 84902491670     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000361     Document Type: Editorial

References (20)

1. Patel GP, Balk RA: Systemic steroids in severe sepsis and septic shock. Am J Respir Crit Care Med 2012; 185:133-139
2. Bernard GR, Luce JM, Sprung CL, et al: High-dose corticosteroids in patients with the adult respiratory distress syndrome. N Engl J Med 1987; 317:1565-1570
3. Bone RC, Fisher CJ Jr, Clemmer TP, et al: A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock. N Engl J Med 1987; 317:653-658
4. Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis: The Veterans Administration Systemic Sepsis Cooperative Study Group. N Engl J Med 1987; 317:659-665
5. Briegel J, Forst H, Haller M, et al: Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 1999; 27:723-732
6. Annane D, Sébille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288:862-871
7. Sprung CL, Annane D, Keh D, et al; CORTICUS Study Group: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
8. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013; 41:580-637
9. Angus DC, van der Poll T: Severe sepsis and septic shock. N Engl J Med 2013; 369:840-851
10. Moran JL, Graham PL, Rockliff S, et al: Updating the evidence for the role of corticosteroids in severe sepsis and septic shock: A Bayesian meta-Analytic perspective. Crit Care 2010; 14:R134
11. Contrael KM, Killian AJ, Gregg SR, et al: Prescribing patterns of hydrocortisone in septic shock: A single-center experience of how surviving sepsis guidelines are interpreted and translated into bedside practice. Crit Care Med 2013; 41:2310-2317
12. Bruno JJ, Dee BM, Anderegg BA, et al: US practitioner opinions and prescribing practices regarding corticosteroid therapy for severe sepsis and septic shock. J Crit Care 2012; 27:351-361
13. Katsenos CS, Antonopoulou AN, Apostolidou EN, et al; on behalf of the Hellenic Sepsis Study Group: Early Administration of Hydrocortisone Replacement After the Advent of Septic Shock: Impact on Survival and Immune Response. Crit Care Med 2014; 42:1651-1657
14. Handel D, Epstein S, Khare R, et al: Interventions to improve the timeliness of emergency care. Acad Emerg Med 2011; 18:1295-1302
15. Galeski DF, Pines J, Band RA, et al: Impact of time to antibiotics on survival in patients with severe sepsis or septic shock in whom early goal-directed therapy was initiated in the emergency department. Crit Care Med 2010; 38:1-9
16. Marik PE, Baram M, Vahid B: Does central venous pressure predict fluid responsiveness? A systematic review of the literature and the tale of seven mares. Chest 2008; 134:172-178
17. Thomas Z, Bandali F, McCowen K, et al: Drug-induced endocrine disorders in the intensive care unit. Crit Care Med 2010; 38:S219-S230
18. Kakizaki Y, Watanobe H, Kohsaka A, et al: Temporal profiles of interleukin-1beta, interleukin-6, and tumor necrosis factor-Alpha in the plasma and hypothalamic paraventricular nucleus after intravenous or intraperitoneal administration of lipopolysaccharide in the rat: Estimation by push-pull perfusion. Endocr J 1999; 46:487-496
19. Kaushal N, Ramesh V, Gozal D: TNF-α and temporal changes in sleep architecture in mice exposed to sleep fragmentation. PLoS One 2012; 7:e45610
20. Marik PE, Pastores SM, Annane D, et al; American College of Critical Care Medicine: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008; 36:1937-1949